Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue Sarcoma

Advanced Melanoma ◽

Isolated Limb Perfusion ◽

Limb Perfusion ◽

Factor Α ◽

Isolated Limb Perfusion With Tumor Necrosis Factor α and Melphalan for Locally Advanced Soft Tissue Sarcoma: The Value of Adjuvant Radiotherapy

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70501-3 ◽

2007 ◽

Vol 2007 ◽

pp. 330-333

Author(s):

E. Glatstein

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Adjuvant Radiotherapy ◽

Tumor Necrosis ◽

Locally Advanced ◽

Advanced Soft Tissue Sarcoma ◽

Limb Perfusion ◽

Factor Α ◽

Effects of Isolated Limb Perfusion With Tumor Necrosis Factor-α on Circulating Levels of Proinflammatory Cytokines

Journal of Immunotherapy ◽

10.1097/00002371-200107000-00011 ◽

2001 ◽

Vol 24 (4) ◽

pp. 354-362 ◽

Cited By ~ 5

Author(s):

Patrizia Ferroni ◽

Franco Di Filippo ◽

Francesca Martini ◽

Antonella Spila ◽

Roberta D'Alessandro ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Proinflammatory Cytokines ◽

Tumor Necrosis ◽

Isolated Limb Perfusion ◽

Limb Perfusion ◽

Factor Α ◽

Circulating Levels ◽

High dose tumor necrosis factor-? and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation

Cancer ◽

10.1002/(sici)1097-0142(19970315)79:6<1129::aid-cncr11>3.0.co;2-1 ◽

1997 ◽

Vol 79 (6) ◽

pp. 1129-1137 ◽

Cited By ~ 118

Author(s):

Mordechai Gutman ◽

Moshe Inbar ◽

Dina Lev-Shlush ◽

Subhi Abu-Abid ◽

Martha Mozes ◽

...

Keyword(s):

Soft Tissue ◽

Tumor Necrosis Factor ◽

Soft Tissue Sarcoma ◽

Tumor Necrosis ◽

Response Rate ◽

Isolated Limb Perfusion ◽

High Dose ◽

Limb Preservation ◽

Limb Perfusion ◽

Anesthesiologists' Management of Isolated Limb Perfusion with “High-dose” Tumor Necrosis Factor α

Anesthesiology ◽

10.1097/00000542-199312000-00039 ◽

1993 ◽

Vol 79 (6) ◽

pp. 1433-1437 ◽

Cited By ~ 10

Author(s):

Gisli H. Sigurdsson ◽

Bernhard Nachbur ◽

Ferdy J. Lejeune

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Isolated Limb Perfusion ◽

High Dose ◽

Limb Perfusion ◽

Factor Α ◽

Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor-α and melphalan

Critical Care Medicine ◽

10.1097/00003246-200004000-00021 ◽

2000 ◽

Vol 28 (4) ◽

pp. 1040-1046 ◽

Cited By ~ 26

Author(s):

Christoph Kettelhack ◽

Peter Hohenberger ◽

Guntram Schulze ◽

Berit Kilpert ◽

Peter M. Schlag

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Human Tumor ◽

Isolated Limb Perfusion ◽

Human Tumor Necrosis Factor ◽

Limb Perfusion ◽

Factor Α ◽

Low-dose tumor necrosis factor-α augments antitumor activity of stealth liposomal doxorubicin (DOXIL®) in soft tissue sarcoma-bearing rats

International Journal of Cancer ◽

10.1002/1097-0215(20000915)87:6<829::aid-ijc12>3.0.co;2-c ◽

2000 ◽

Vol 87 (6) ◽

pp. 829-837 ◽

Cited By ~ 60

Author(s):

Timo L.M. Ten Hagen ◽

Alexander H. Van Der Veen ◽

Peet T.G.A. Nooijen ◽

Sandra T. Van Tiel ◽

Ann L.B. Seynhaeve ◽

...

Keyword(s):

Soft Tissue ◽

Tumor Necrosis Factor ◽

Soft Tissue Sarcoma ◽

Antitumor Activity ◽

Tumor Necrosis ◽

Low Dose ◽

Liposomal Doxorubicin ◽

Factor Α ◽

Isolated Limb Perfusion With High-Dose Tumor Necrosis Factor α and Melphalan for Kaposi Sarcoma

Archives of Surgery ◽

10.1001/archsurg.134.2.177 ◽

1999 ◽

Vol 134 (2) ◽

pp. 177 ◽

Cited By ~ 26

Author(s):

Dina Lev-Chelouche

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Kaposi Sarcoma ◽

Isolated Limb Perfusion ◽

High Dose ◽

Limb Perfusion ◽

Factor Α ◽

A rat extremity soft tissue sarcoma model for the study of systemic treatment with Stealth® liposome-encapsulated tumor necrosis factor-α and cytotoxic agents

Advanced Drug Delivery Reviews ◽

10.1016/s0169-409x(96)00465-6 ◽

1997 ◽

Vol 24 (2-3) ◽

pp. 245-256 ◽

Cited By ~ 5

Author(s):

Timo L.M. ten Hagen ◽

Alexander M.M. Eggermont

Keyword(s):

Soft Tissue ◽

Tumor Necrosis Factor ◽

Soft Tissue Sarcoma ◽

Tumor Necrosis ◽

Systemic Treatment ◽

Cytotoxic Agents ◽

Extremity Soft Tissue Sarcoma ◽

Factor Α ◽

Hyperthermic Isolated Limb Perfusion With Low-Dose Tumor Necrosis Factor-α and Melphalan for Bulky In-Transit Melanoma Metastases

Annals of Surgical Oncology ◽

10.1245/aso.2004.03.019 ◽

2004 ◽

Vol 11 (2) ◽

pp. 173-177 ◽

Cited By ~ 51

Author(s):

Carlo Riccardo Rossi ◽

Mirto Foletto ◽

Simone Mocellin ◽

Pierluigi Pilati ◽

Mario Lise

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Low Dose ◽

Isolated Limb Perfusion ◽

Limb Perfusion ◽

Melanoma Metastases ◽

Factor Α ◽

In Transit ◽

Cancer Treatment and Research - Soft Tissue Sarcomas: Present Achievements and Future Prospects ◽

Isolated limb perfusion with high-dose tumor necrosis factor-α for locally advanced extremity soft tissue sarcomas

10.1007/978-1-4615-6121-7_13 ◽

1997 ◽

pp. 189-203 ◽

Cited By ~ 16

Author(s):

A. M. M. Eggermont ◽

H. Schraffordt Koops ◽

J. M. Klausner ◽

P. M. Schlag ◽

B. B. R. Kroon ◽

...

Keyword(s):

Soft Tissue ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Locally Advanced ◽

Soft Tissue Sarcomas ◽

High Dose ◽

Limb Perfusion ◽

Factor Α ◽